4 results on '"Tang, Weizhong"'
Search Results
2. Novel Model to Predict the Prognosis of Patients with Stage II–III Colon Cancer.
- Author
-
Xu, Yansong, Liang, Fangfang, Chen, Yi, Wang, Zhen, Zhong, Huage, and Tang, Weizhong
- Subjects
C-reactive protein ,CANCER patients ,CANCER invasiveness ,COLON tumors ,LYMPH nodes ,MATHEMATICAL models ,METASTASIS ,MULTIVARIATE analysis ,OPERATIVE surgery ,TUMOR antigens ,TUMOR classification ,THEORY ,KAPLAN-Meier estimator ,DISEASE risk factors - Abstract
Different opinions exist on the relationship between the C-reactive protein-to-albumin ratio (CAR) and the prognosis of colon cancer. This study is aimed at evaluating the relationship between CAR and prognosis of stage II–III colon cancer and establishing a clinical prognosis model. Patients were randomised to a training set (566 cases) and validation set (110 cases). The relationship between CAR and clinicopathological variables was calculated, and the Kaplan-Meier method was used to analyse the overall survival (OS) rate of colon cancer. In the training set, colon cancer independent risk factors were included in the prognosis model and then tested in the validation set. The accuracy and discrimination of the model were assessed using the C-index and calibration curves. Compared with patients with low CAR, patients with high CAR showed significantly poorer survival (P = 0.020). In the multivariate analysis, CAR, carcinoembryonic antigen (CEA), lymph node metastasis, operation mode, and perineural invasion were identified as independent prognostic indicators and adopted to establish the prediction model. The C-index of the nomogram for predicting OS reached 0.751 in the training set and 0.719 in the validation set. The calibration curve exhibited good consistency. In the present study, the CAR may be an independent prognostic factor for stage II–III colon cancer, and the nomogram has a certain predictive value. However, further prospective large-sample research needs to be conducted to validate our findings. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
3. Nomogram for predicting overall survival in stage II‐III colorectal cancer.
- Author
-
Liu, Jungang, Huang, Xiaoliang, Yang, Wenkang, Li, Chan, Li, Zhengtian, Zhang, Chuqiao, Chen, Shaomei, Wu, Guo, Xie, Weishun, Wei, Chunyin, Tian, Chao, Huang, Lingxu, Jeen, Franco, Mo, Xianwei, and Tang, Weizhong
- Subjects
MEAN platelet volume ,NOMOGRAPHY (Mathematics) ,COLORECTAL cancer ,TUMOR classification ,REGRESSION analysis ,ADJUVANT treatment of cancer - Abstract
Purpose: The overall survival (OS) of patients diagnosed with stage II‐III colorectal cancer (CRC) can vary greatly, even between patients with the same tumor stage. We aimed to design a nomogram to predict OS in resected, stage II‐III CRC and stratify patients with CRC into different risk groups. Patients and Methods: Based on data from 873 patients with CRC, we used univariate Cox regression analysis to select the significant prognostic features, which were subjected to the least absolute shrinkage and selection operator (LASSO) regression algorithm for feature selection. Cross‐validation was used to confirm suitable tuning parameters (λ) for LASSO logistic regression. Then, the nomogram was used to estimate 3‐ and 5‐year OS based on the multivariable Cox regression model. The survival curves of the two groups were produced using the Kaplan‐Meier method. Risk group stratification was performed to assess the predictive capacity of the nomogram. Results: Preoperative mean platelet volume, preoperative platelet distribution width, monocytes, and postoperative adjuvant chemotherapy were identified as independent prognostic factors by LASSO regression and integrated for the construction of the nomogram. The nomogram provided good discrimination, with C‐indices of 0.67 and 0.69 for the training and validation sets, respectively. Calibration plots illustrated excellent agreement between the nomogram predictions and actual observations for 3‐ and 5‐year OS. Moreover, a significant difference in OS was shown between patients stratified into different risk groups (P <.001). Conclusion: We constructed and validated an original predictive nomogram for OS in patients with CRC after surgery, facilitating physicians to appraise the individual survival of postoperative patients accurately and identify high‐risk patients who need more aggressive treatment and follow‐up strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
4. Evaluation of Red Cell Distribution Width to Lymphocyte Ratio as Potential Biomarker for Detection of Colorectal Cancer.
- Author
-
Huang, Jiahao, Zhao, Yang, Liao, Lin, Liu, Shun, Lu, Shaolong, Wu, Changtao, Wei, Chuanyi, Xu, Shaoqiang, Zhong, Huage, Liu, Junjie, Guo, Yun, Zhang, Sen, Gao, Feng, and Tang, Weizhong
- Subjects
ERYTHROCYTES ,BIOMARKERS ,BLOOD testing ,COLON tumors ,RECTUM tumors ,TUMOR classification ,RETROSPECTIVE studies ,RECEIVER operating characteristic curves ,COLON polyps ,LYMPHOCYTE count - Abstract
Background and Aim. Colorectal cancer (CRC) is the third most lethal cancer globally. This study sought to determine the feasibility of using red cell distribution width-to-lymphocyte ratio (RLR) as a tool to facilitate CRC detection. Methods. Seventy-eight healthy controls, 162 patients diagnosed with CRC, and 94 patients with colorectal polyps (CP) from June 2017 to October 2018 were retrospectively reviewed. Clinical data were obtained to analyze preoperative RLR level, and receiver operating characteristic (ROC) curve analysis was performed to estimate the potential role of RLR as a CRC biomarker. Results. RLR was higher in patients with CRC than in healthy participants (P < 0.05). ROC analysis indicated that combined detection of RLR and CEA appears to be a more effective marker to distinguish among controls, CP, and CRC patients, yielding 56% sensitivity and 90% specificity. RLR levels were significantly greater in those who had more advanced TNM stages (P < 0.05) and patients with distant metastasis stages (P < 0.05). Conclusions. RLR might serve as a potential biomarker for CRC diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.